Home

Nantahala Capital Management reported a 7.54% stake in Inhibikase Therapeutics IKT · 5,298,624 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
7.54%
Last report
First report
Shares held
5,298,624 sh
Class
Common Stock, $0.001 par value
Event date
24/12/31
Filed
25/02/14

First 5%+ report · 7.54% stake

Inhibikase Therapeutics trades, last 26 weeks

What else happened in Inhibikase Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/01~25/01/30

Nantahala Capital Management's other 5% stake reports

Nantahala Capital Management reported a 7.54% stake in Inhibikase Therapeutics IKT · 5,298,624 sh · passive holder | Whalegun